The Firm represents Chinese companies doing business in the People's Republic of China or seeking to raise debt or equity capital in the United States, as well as investment banks and hedge funds seeking to invest in or expand their businesses in China. The Firm has been involved in numerous transactions in China including initial and secondary public offerings; general corporate and ongoing public company representation; alternative public offerings and reverse mergers; SPACs (including Chardan 2008 Acquisition, the first NASDAQ listed SPAC), PIPEs, private equity and debt financings; venture capital financing; mergers and acquisitions; and joint ventures.

We represent public and private companies in China in a variety of industries. Our reverse merger/alternative public offering practice has significantly expanded this year and has led us to add a third attorney who is fluent in Mandarin. We also have attorneys who are fluent in Cantonese and Shanghai dialects. Our Firm provides a broad range of services for our Chinese clients including assisting them with fund raising needs.

Lawyers from the Firm regularly visit China and speak at conferences on matters related to the Firm's China practice.